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Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with poor prognosis due
to resistance to conventional chemotherapy and limited efficacy of radiotherapy. Our previous studies have indicated that
expression of Hepatitis B virus pre-S2 large mutant surface antigen (HBV pre-S2D) is associated with a significant risk of
developing HCC. However, the relationship between HBV pre-S2D protein and the resistance of chemotherapeutic drug
treatment is still unclear.
Methodology/Principal Findings: Here, we show that the expression of HBV pre-S2D mutant surface protein in Huh-7 cell
significantly promoted cell growth and colony formation. Furthermore, HBV pre-S2D protein increased both mRNA
(2.760.5-fold vs. vehicle, p=0.05) and protein (3.260.3-fold vs. vehicle, p=0.01) levels of Bcl-2 in Huh-7 cells. HBV pre-S2D
protein also enhances Bcl-2 family, Bcl-xL and Mcl-1, expression in Huh-7 cells. Meanwhile, induction of NF-kB p65, ERK, and
Akt phosphorylation, and GRP78 expression, an unfolded protein response chaperone, were observed in HBV pre-S2D and
HBV pre-S-expressing cells. Induction of Bcl-2 expression by HBV pre-S2D protein resulted in resistance to 5-fluorouracil
treatment in colony formation, caspase-3 assay, and cell apoptosis, and can enhance cell death by co-incubation with Bcl-2
inhibitor. Similarly, transgenic mice showed higher expression of Bcl-2 in liver tissue expressing HBV pre-S2D large surface
protein in vivo.
Conclusion/Significance: Our result demonstrates that HBV pre-S2D increased Bcl-2 expression which plays an important
role in resistance to 5-fluorouracil-caused cell death. Therefore, these data provide an important chemotherapeutic strategy
in HBV pre-S2D-associated tumor.
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Introduction
Hepatocellular carcinoma (HCC) is a common malignancy
affecting approximately one million people worldwide annually
[1]. It is one of the most common causes of cancer morbidity and
mortality in Asia and Africa. Hepatocellular neoplasms develop
regularly from preneoplastic foci of altered hepatocytes, and
hepatocellular cancer occurs both sporadically and in relation to
chronic viral infection [2], environmental exposure [3], extensive
alcohol intake [4], transgenic oncogenes [5,6,7] and alternative
causes of hepatic cirrhosis. HBV is considered a major etiological
factor in the development of HCC. Chronic HBV carriers have a
greater than 100 fold increased relative risk of developing HCC,
although the oncogenic mechanisms of HBV are not completely
understood [8,9]. HBV encodes three envelope proteins in the
pre-S/S open reading frame that are named large, middle, and
small surface proteins. The expression of HBV surface proteins is
related to liver tumor development and a number of truncated
surface gene mutants with a partially deleted pre-S region were
already identified [10,11,12,13,14]. One of the major mutant
types is the deletion of the pre-S2 region (pre-S2D). These pre-S2D
mutants are becoming increasingly prevalent in serum and liver
tissues of patients with chronic HBV infection and HCC
[15,16,17].
HBV surface mutant pre-S2D gene is deleted in approximately
nucleotides 2 to 55 of the pre-S2 region and often contains a point
mutation in the start codon of the pre-S2 region. The pre-S2D
type of HBV large surface mutant protein is predominant in
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Based on epidemiologic studies, HBV carriers who presented with
the pre-S2D mutant protein in serum had worse disease outcomes
than those who did not [20]. Overexpression of pre-S2D large
surface proteins has been demonstrated in the induction of
endoplasmic reticulum (ER) stress [21]. Unfolded proteins in the
endoplasmic reticulum activate several signaling pathways that are
referred to as the unfolded protein responses (UPR). UPR pathway
has three components in mammalian cells: basic leucine zipper
transcription factor ATF6, IRE1 RNA-processing enzyme, and
ER localized kinase (PERK). Previous studies have indicated that
activation of NF-kB is through calcium release, reactive oxygen
species production, IRE1, and PERK signal pathway during ER
stress [22,23,24,25,26]. We have also characterized the NF-kB
response and found that NF-kB was activated through multiple
pathways, including calcium signaling and pp38 kinase [21].
Activation of NF-kB by ER stress leads to induction of many
cellular genes that are largely anti-apoptosis in function.
HCC is one of the most common malignancies worldwide with
poor prognosis due to resistance to conventional chemotherapy
and limited efficacy of radiotherapy. A major challenge in the
systemic treatment of HCC is cellular resistance to conventional
cytotoxic agents. In addition, many studies have indicated that
alternation of gene expression is correlated with drug resistance,
such as overexpression of protein kinase C, EGF receptor, c-
erbB2, c-ras and c-Bcl-2 in tumor cells [27,28,29,30]. Previous
studies have indicated a high-level expression of Bcl-2 in many
tumor tissues, including HCC [31,32]. The Bcl-2 gene family is a
group of apoptosis-related genes which have been studied
extensively. Bcl-2 protein overexpression is associated with drug
resistance and poor clinical outcome in cancer patients. Apoptosis
is mainly executed by proteases of caspase family, whereby
members of Bcl-2 family, such as Bcl-2, Bcl-xL, or Mcl-1, inhibit
caspase activation [33,34]. The proteins of Bcl-2 family are
important regulators of apoptosis induced by a wide array of
stimuli, including chemotherapeutic drugs.
From our previous study, HBV pre-S2D large surface protein
expression in hepatocytes has been correlated with hepatocarcin-
ogenesis. For patients with cancer who are from HBV-endemic
areas, routine screening for HBsAg before cytotoxic chemotherapy
should be performed, and there was a trend of poorer survival for
patients who had developed severe hepatitis during chemotherapy
[35]. Furthermore, a recent study indicated that a pre-chemo-
therapy for high HBV viral levels is associated with poorer survival
in HCC patients with chronic HBV infection [36], and the
occurrences of HBV pre-S2D large surface proteins in HBV
cancer patients are about 30% in Taiwan [18]. On the other hand,
previous study has also indicated Bcl-2 protein expression in acute
and chronic hepatitis, cirrhosis and hepatocellular carcinoma [37].
However, the relationship between HBV pre-S2D large surface
protein and Bcl-2 expression or drug resistance is still unclear.
Therefore, in this study, we employed HBV pre-S2D large surface
protein expressing cells to analyze altered expressed proteins in
hepatoma Huh-7 and immortalized hepatocyte NeHepLxHT cell
lines. We identified induction of Bcl-2 family overexpression by
HBV pre-S2D large surface protein in Huh-7 cells. Furthermore,
HBV pre-S2D large surface protein expressing cell was more
resistant to 5-fluorouracil treatment. However, the ability of 5-
fluorouracil resistance was significantly decreased by co-incubating
5-fluorouracil with Bcl-2 inhibitor. We found that HBV large
surface protein and HBV pre-S2D large surface protein enhanced
Bcl-2 family expression and resistance to chemotherapeutic 5-
fluorouracil treatment. Taken together, these results suggest that
co-treatment of Bcl-2 inhibitor might be important for chemo-
therapeutic strategy of HBV pre-S2D large surface protein
containing tumor cells.
Materials and Methods
Cell culture and chemicals
Huh-7 and cell line was obtained from ATCC (Manasses, VA,
USA). Huh-7 pre-S2D and Huh-7 pre-S cell lines were generated
from Huh-7. NeHepLxHT and NeHepLxHT pre-S2D cell lines
were gift from Dr. Lily Hui-Ching Wang. NeHepLxHT cell line
was derived by exogenous expression of human telomerase reverse
transcriptase (hTERT) in normal human neonatal hepatocytes.
These cell lines were maintained at 37uC in a 5% CO2
atmosphere in DMEM supplemented with 10% heat-inactivated
fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml
streptomycin (Invitrogen, Ground Island, NY, USA). Culture
medium was replaced every 2 days. ECL Western blot detection
system was purchased from Millipore (Billerica, MA, USA). Anti-
GRP78 was purchased from Transduction Laboratories. Anti-Bcl-
2, anti-Bcl-xL, anti-Mcl-1, anti-Bax, anti-Bak, anti-p-Ser
311-p65,
anti-p65, anti-MCL-1 anti-Bcl-xL, anti-Bax, anti-Bak, anti-ERK,
anti-phospho-p44/42 MAPK, Akt, and p-Thr
308-Akt antibodies
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-p-Ser
276-p65, anti-rabbit IgG-horseradish peroxidase
(HRP) conjugates, and rabbit anti-mouse IgG-HRP conjugates
antibodies were purchased from Cell Signaling (Beverly, MA,
USA). Anti-HA antibody and Bcl-2 inhibitor II, YC137 were
purchased from Calbiochem (San Diego, CA, USA).
Plasmid and Stable Clone Cell Lines Construction
Plasmid pIRES, pIRES-preS-HA, and pIRES-pre-S2D-HA
were gifts from Dr. Wenya Huang. Huh-7 cells were transfected
with pIRES, pIRES-preS-HA, and pIRES-pre-S2D-HA plasmids
using Invitrogen LipofectAMINE 2000 reagent according to the
manufacturer’s protocol. Cells were then selected by G418 for 2
weeks. The expression of HBV large surface proteins in pIRES-
pre-S and pIRES-pre-S2D stable clone cell line were confirmed by
Western blotting.
Western blot analysis
The cell lysates were collected with RIPA lysis buffer (50 mM
Tris-cl pH 7.4. 150 mM NaCl. 1% NP40. 0.25% Na-deoxycho-
late. 1 mM PMSF, 1 mM EDTA; 5 mg/ml Aprotinin.) containing
protease inhibitors (1 mM PMSF, 1 mM orthovanadate, 1 mM
EDTA, and 10 mg/mL: leupeptin). Protein concentrations of cell
lysates were measured using a Micro BCA protein assay reagent
kit (Pierce, Rockford, IL, USA). To the cell lysate, the same
volume of SDS-PAGE sample loading buffer [100 mmol/L Tris-
HCl, 4% SDS, 5% b-mercaptoethanol, 20% glycerol, and 0.1%
bromphenol blue (pH 6.8)] was added, and the cell lysates were
boiled for 10 min. Equal amounts of proteins were resolved in 10
or 12% SDS-polyacrylamide gels and transferred to nitrocellulose
membranes using a semidry transfer cell. The blotted membrane
was washed twice with TBS containing 0.1% Tween 20 (TBST;
10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20).
After blocking with TBST containing 5% nonfat milk for 1 h, the
membranes were probed with the following antibodies against:
HA, b-actin (43 Kda), GRP78 (78 kDa), Bcl-2 (26 kDa), p65
(65 kDa), p-Ser276-p65 (65 kDa), p-Ser311-p65 (65 kDa), Bcl-xL
(30 kDa)), MCL-1 (40 kDa), Bax (23 kDa), Bak (30 kDa), Akt
(62 kDa), pAkt (62 kDa), ERK (44 kDa), and pERK (44 kDa)
antibodies in 1% TBST nonfat milk at 4uC overnight. The
membrane was washed thrice with TBST for a total of 15 min.
The secondary anti-mouse IgG-HRP conjugates or anti-rabbit
Induction of Bcl-2 by HBV Pre-S2 Mutant Protein
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28977IgG-HRP conjugates (1:2,000 dilutions) was subsequently incu-
bated with the membrane for 1 h at room temperature and was
washed extensively for 50 min with TBST. The blots were
visualized with the enhanced chemiluminescence (GE, Pittsburgh,
PA, USA), and according to the manufacturer’s instructions. The
blots were developed with the ECL-Western blot detection system
according to the manufacturer’s instruction.
Cell viability
Cell viability was assessed using the trypan blue staining assay in
three replicates. Huh-7 and stable transfectant cells were seeded at
1610
4 per well in 24-well flat-bottomed plates and incubated in
10% FBS–supplemented DMEM for 24 h. Cells were treated with
0.1, 0.25, and 0.5 mM 5-fluorouracil in the same medium.
Controls received the DMSO vehicle at a concentration same as
that in drug-treated cells. After 4 days, cell viability was
determined by trypan blue exclusion and microscopy examination.
Semi-quantitative RT-PCR
The cells were washed with cold PBS and then harvested. Total
RNA was extracted using Trizol Reagent (Invitrogen, Ground
Island, NY, USA). The cDNA was reverse-transcribed from 1 mg
of total RNA using oligo(dT) primers and Moloney murine
leukemia-virus transcriptase. The following primer sequences were
employed to detect Bcl-2 transcripts: sense (59-GCACC-
CACTCCCTTCATACAAT-39) and antisense (59-ACGCAGGT-
TACATTCGTCTTCC-39. PCR reaction was performed as
follows: reverse transcription at 42uC for 60 min and denaturation
at 72uC for 2 min; then amplification for 30 cycles at 94uC for
30 s, annealing at 56uC for 30 s, and extension at 72uC for 30 s,
followed by a terminal elongation step at 72uC for 10 min and a
final holding stage at 4uC). Meanwhile, the same amount of cDNA
was amplified for 25 cycles using specific glyceraldehyde-3-
phosphate dehydrogenase primers: 59-TGAAGGTCGGTGT-
GAACGGATTTGGC-39 (sense) and 59-CATGTAGGCCAT-
GAGGTCCACCAC-39 (antisense). The products were visualized
after electrophoresis on a 1.5% agarose gel containing ethi-
dium bromide. The signal level of the bands was quantified
densitometrically.
Colony formation assay
For colony formation, Huh-7 and stable transfectant cells were
seeded at 1000 per well in 6-well flat-bottomed plates and
incubated in 10% FBS–supplemented DMEM for 24 h. The cells
were treated with 5-fluorouracil as dose indicated and 0.25 mM 5-
fluorouracil plus 1 or 5 mM Bcl-2 inhibitor (Bcl-2 inhibitor II,
YC137) for 24 h. The culture medium was replenished, and cells
were maintained at 37uC for 14 days with medium changed every
other day. Grown colonies were fixed with 3.7% formaldehyde
and stained with crystal violet. The number of cell colonies was
determined directly on each well.
Analysis of caspase-3 activity
Caspase-3 activity was determined using PE active caspase-3
apoptosis kit (BD Pharmingen). Briefly, Huh7 V, pre-S, and pre-
S2D (5610
5) cells in 10-cm dishes were subjected to different drug
treatments as indicated for 72 h and were resuspended cells in
0.5 ml Cytofix/Cytoperm solution for 20 min on ice. Further-
more, cells were incubates in 100 ml of Perm/Wash buffer
containing 20 ml caspase-3 antibody for 30 min at room
temperature. Each sample was then added with 400 ml Perm/
Wash buffer, and caspase-3 activity signals were analyzed by flow
cytometry.
Annexin V/propidium iodide assay
For assessment of apoptosis, both floating and adherent cells
were collected and analyzed. Briefly, 5610
5 cells per dish were
plated onto 6-cm dishes and incubated at 37uC for 16 h. The cells
were treated with 5-fluorouracil alone or plus Bcl-2 inhibitor for
24 h. The cells were washed twice with PBS and collected by
trypsinization. After centrifugation at 4006 g for 5 min at room
temperature, the cells were stained with Annexin V and propidium
iodide (1 mg/mL). The cell apoptosis distributions were deter-
mined on a FACScort flow cytometer and analyzed by ModFitLT
V3.0 software program.
Transgenic Mice Tissue Protein Extraction
The transgenic mouse liver tissues were gifts from Dr. Ih-Jen
Su. The pre-S2D transgenic mice were constructed by injection of
pre-S2D gene fragment into the male pronucleus of fertilized
mouse ova. Microinjection was performed in Fvb/n mice. After
12 months, liver tissue from pre-S2D transgenic mice was
homogenized in RIPA buffer (50 mM Tris-HCl (pH 7.4), 1%
Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl,
1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml
aprotinin, leupeptin, and pepstatin, 1 mM Na3VO4, and 1 mM
NaF). Homogenates were centrifuged at 15,0006g for 10 min at
4uC, and the supernatants were collected. Total protein
concentrations of the tissue lysates were quantified using the
Micro BCATM protein assay reagent kit following the manufac-
turer’s instructions.
Immunohistochemical Staining
Immunohistochemical staining was performed on depar-affi-
nized tissue sections of formalin-fixed material. For immunohis-
tochemical staining, 4-mm-thick paraffin sections were stained
with mouse anti-preS or anti-Bcl-2. The primary antibodies and
working dilutions were as follows: HBsAg (1:500, 7H11; gift from
Dr. Wenya Huang), Bcl-2 (1:100, polyclonal N-19; Santa Cruz
Biotechnology, Santa Cruz, CA). Detection was done with
streptavidin-biotinylated peroxidase-conjugated reagents (LSAB+
kit; DAKO, Carpinteria, CA). A biotinylated anti-mouse second-
ary antibody (DAKO) was then applied and incubated with
peroxidase-conjugated streptoavidin, chromogenized by 3-amino-
9-ethylcarbazole.
Statistical Analysis
Results were presented as the mean 6 S.D., and statistical
comparisons were made using the Student’s t test. Significance was
defined at the p,0.05 or 0.01 levels.
Results
Expression of pre-S and pre-S2D proteins in Huh-7 cell
To establish the expression of HBV pre-S large surface
protein and HBV pre-S2D large surface protein in hepatoma
Huh-7 cell line. HBV large surface wild type HBS gene and
mutant HBS gene were constructed into pIRES plasmid
(Fig. 1A). Huh-7 cells were transfected with pIRES, pIRES-
pre-S-HA, and pIRES-pre-S2D-HA plasmids, and the trans-
fectants were selected with G418. The expression of HBV large
surface proteins in pIRES-pre-S2D-HA and pIRES-pre-S-HA
stable clone cell lines were confirmed by Western blotting. The
result shows that HBV pre-S large surface protein and HBV
pre-S2D large surface protein can be expressed in Huh-7 cells
(Fig. 1B).
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The characteristics of pre-S and pre-S2D large surface proteins
in Huh-7 cells are investigated for cell growth rate. The stable cell
lines of pre-S and pre-S2D large surface proteins were confirmed
using trypan blue staining assay and colony formation assay. The
result indicated that the growth rate of pre-S and pre-S2D stable
cell lines increased at 72–96 h (Fig. 2A). Furthermore, in order to
eliminate the possibility that pre-S and pre-S2D large surface
proteins affect the colony-forming ability in Huh-7 cell line, we
determined the number colonies in Huh-7 cells cultured for 14
days. As shown in Fig. 2B, Huh-7 pre-S2D cells produced the
largest number of colonies, 39967. Huh-7 pre-S cells produced
fewer colonies, 30766, and Huh-7 V cells produced the smallest
number of colonies, 24265 (Fig. 2B).
Induction of Bcl-2 family expression in Huh-7 pre-S2D
large surface protein cell line
Many studies have indicated that overexpression of Bcl-2
family was correlated with chemotherapeutic drug resistance. To
observe the effect of pre-S2D and pre-S large surface proteins on
Bcl-2 family expression in Huh-7 cells, the expression of Bcl-2
was determined by RT-PCR and Western blotting assay for Huh-
7 V, Huh-7 pre-S2D, and Huh-7 pre-S cell line with specific Bcl-
2 primer and Bcl-2 antibody. First, the total RNA was extracted
from three Huh-7 stable cell lines, and RT-PCR to quantify the
Bcl-2 mRNA. High expression of Bcl-2 mRNA was observed in
hepatoma cells that express the deletion forms of HBV large
surface proteins (Fig. 3A and Fig. 3B). Furthermore, the result
shows that the expression levels of Bcl-2 protein were significantly
increased in Huh-7 pre-S2D cell. For example, expression level of
Bcl-2 in Huh-7 pre-S2D cell was enhanced to about 3-fold
compared with that in Huh-7 V cell (Fig. 3C and Fig. 3D). To
reconfirm the induction of Bcl-2 expression by pre-S2D proteins,
we analyzed three additional clones of pre-S2D stable cell lines
for the levels of Bcl-2 expression. The result shown that increased
of Bcl-2 protein expression was also observed in those three
additional preS-S2D stable cell lines (Fig. 3E). Furthermore, to
evaluate the event of induction of Bcl-2 expression by pre-S2D
proteins manner in human hepatocyte, Bcl-2 expression level was
determined in NeHepLxHT and NeHepLxHT pre-S2D cell
lines. The result indicated that expression of Bcl-2 was increased
by pre-S2D proteins in human hepatocyte NeHepLxHT cells
(Fig. 3F).
Increased Bcl-2 family expression in Huh-7 pre-S2D large
surface protein cell line
Induction of Bcl-2 expression by pre-S2D proteins was observed
in Huh-7 cells. Furthermore, expression of Bcl-2 family was also
estimated in Huh-7 V, pre-S2D, and pre-S cell lines, and the data
indicated that Bcl-2 family, Bcl-xL and MCL-1, were increased in
Huh-7 pre-S2D cells (Fig. 4A). For example, the Bc-xL and MCL-
1 expression levels in Huh-7 pre-S2D cells were enhanced to about
2.5 and 3-fold compared with Huh-7 V cells (Fig. 4B). Notably,
Bcl-xL expression levels were also induced to about 2-fold in Huh-
7 pre-S cells.
Induction of NF-kB, Akt and ERK phosphorylation by HBV
pre-S2D and pre-S large surface protein
Previous studies have indicated that expression of viral protein
can cause ER stress and NF-kB activation [21,38,39]. Our
previous results also demonstrated that ER stress induced NF-kB
activation and nuclear localization. Therefore, to investigate the
effect of pre-S2D and pre-S large surface proteins on ER stress
and NF-kB activation in Huh-7 cells, the expression of GRP78
and NF-kB phosphorylation were analyzed by Western blotting.
The expression of GRP78, an unfolded protein response
chaperone, was enhanced by HBV pre-S2D and pre-S large
surface proteins. Phosphorylation of NF-kB at ser276 and ser311
sites was increased in HBV pre-S2D and pre-S-expressing cells
(Fig. 5A). In addition, the ERK MAP kinase and PI3-kinase/Akt
pathways are major intracellular signaling modules, which are
known to regulate diverse cellular processes including cell
proliferation, survival and malignant transformation. The ERK
and Akt phosphorylation status were determined by Western
blotting. The result shows that induction of ERK and Akt
phosphorylation were observed in Huh-7 pre-S2D and pre-S cell
lines (Fig. 5B).
Differential susceptibility of Huh-7 V, Huh-7 pre-S2D, and
Huh-7 pre-S cell lines to 5-fluorouracil-induced cell death
The in vitro antitumor efficacy of 5-fluorouracil in three human
HCC stable cell lines, Huh-7 V, Huh-7 pre-S2D, and Huh-7 pre-S
were evaluated. As these three stable cell lines harbor vector only
and different HBV large surface proteins, these stable cell lines
were treated with 5-fluorouracil at different doses indicated. To
investigate whether HBV pre-S2D large protein was involved in
cytotoxic drug resistance mechanisms, the cell viability was
determined by trypan blue staining assay and colony formation.
As shown in Figure 5A, the 72-hour 5-fluorouracil treatment
resulted in dose-dependent, progressive morphological changes
from flat to round in Huh-7 V and Huh-7 pre-S cells. In contrast,
only minor morphologic changes in Huh-7 pre-S2D cells were
observed after 72-hours 5-fluorouracil treatment (Fig. 6A). They
showed differential susceptibility to the antiproliferative effect of 5-
fluorouracil. Huh-7 pre-S2D cells exhibited better cell survival
Figure 1. Expression of HBV pre-S2D large surface protein in
Huh-7 cells. Schematic representation of various lengths of HBV
surface protein. (A) The pre-S represents full length (384 a.a). S
represents C-terminal of pre-S2D (158–384 a.a.) Numbers in each
construct correspond to amino acid positions. The arrow represents the
point mutation of pre-S2 start codon from ATG to ATA. Gray box
indicates pre-S2 deletion region. (B) Huh-7 cells were transfected with
pIRES-pre-S2D-HA (pre-S2D), pIRES-pre-S-HA (pre-S), or pIRES vector
control (V). The expression of pre-S2D protein and pre-S in Huh-7 cells
were analyzed by Western blotting with antibody for HA. b-actin was
used as a loading control.
doi:10.1371/journal.pone.0028977.g001
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the effect of 5-fluorouracil on these three cell lines was evaluated
by colony formation assay (Fig. 6C). The number of colonies was
quantified from violet staining and Huh-7 pre-S2D exhibited
largest number of colonies after 5-fluorouracil treatment (Fig. 6D).
It is noteworthy that Huh-7 pre-S cell produced more colonies
than Huh-7 V cell. To assess the effect of 5-fluorouracil on cell
apoptosis, caspase-3 activity was also determined. Flow cytometric
analysis of caspase-3 activity showed that 5-fluorouracil treatment
was significantly increased caspase-3 activity in Huh-7 V and
Figure 2. HBV pre-S2D large surface protein increases cell growth and colony formation. (A) The effect of HBV large surface protein on
Huh-7 growth rate was determined and cells were maintained in FBS–supplemented DMEM for 4 days, and the number of cells was assessed by
trypan blue staining assay. (B) Huh-7 stable cell lines were analyzed for colony formation ability by colony formation assay, and colony formation was
scored after 7 days. The number of colonies in the graphs was representative of three independent experiments (lower panel). Data represent the
mean 6 SD (n=3). Significant differences (*, P,0.05 and **, P,0.01) between the control and experimental group are marked with an asterisks.
doi:10.1371/journal.pone.0028977.g002
Figure 3. Elevated Bcl-2 expression in HBV pre-S2D cells. (A) Total RNA was isolated from Huh-7 -V, Huh-7 pre-S2D, and Huh-7 pre-S cells and
then subjected to RT-PCR analysis with Bcl-2 and G3APDH specific primers. (B) For Huh-7 -V, Huh-7 pre-S2D, and Huh-7 pre-S cells, the relative levels
of Bcl-2 mRNA were quantified. The data represent the mean of Bcl-2 mRNA expression level from three independent experiments. Columns, mean;
bars, SD (n=3). Significant differences (**, P,0.01) between the control and experimental group are marked with an asterisks. (C) The cell lysates
collected from three stable clones, and cell lysates were analyzed by Western blotting analysis with antibodies for hemagglutinin (HA) tag, Bcl-2, and
b-actin. (D) The levels of Bcl-2 protein in the graphs were representative of three independent experiments (lower panel). Columns, mean; bars, SD
(n=3). Significant differences (**, P,0.01) between the control and experimental group are marked with an asterisks. (E) Furthermore, expression
level of Bcl-2 was determined by using Western blotting in three individual pre-S2D stable cell lines. (F) Expression level of Bcl-2 was enhanced by pre-
S2D in the immortalized human hepatocyte cell line. Total cell lysate from NeHep and NeHep-pre-S2D were determined by Western blotting analysis
with Bcl-2, pre-S, and b-actin specific antibosies.
doi:10.1371/journal.pone.0028977.g003
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(Fig. 6E). For example, 5-fluorouracil caused 4.2-fold and 3.5-fold
increases in caspase-3 activity at 0.25 mM treatment for Huh-7 V
and Huh-7 pre-S cell lines. However, caspase-3 activity in Huh-7
pre-S2D cells, there is only 2.5-fold increased after 5-fluorouracil
treatment (Fig. 6F).
Bcl-2 inhibitor decreased colony formation and increased
caspase-3 activity in Huh-7 pre-S2D cells under
5-fluorouracil treatment
We observed that induction of Bcl-2 expression was enhanced by
HBV pre-S2D large protein in Huh-7 cells, and the cells were
resistant to 5-fluorouracil treatment. To determine whether the
induction Bcl-2 expression by HBV pre-S2D large protein was
corrected with resistant to 5-fluorouracil in Huh-7 cells, the
combined effect of Bcl-2 inhibitor (Bcl-2 Inhibitor II, YC137) and
5-fluorouracil was evaluated by colony formation assay, caspase-3
activity assay. First of all, cells were exposed to 5-fluorouracil agent
or a combination of 5-fluorouracil with Bcl-2 inhibitor II, YC137.
After incubation, the number of colonies was determined by
stainingwith crystal violet (Fig. 7A). The data show us that when co-
incubated 0.25 mM 5-fluorouracil with 1 mMo r5 mM Bcl-2
inhibitor, it significantly decreased colony formation ability in Huh-
7 pre-S2D and Huh-7 pre-S cells (Fig. 7B). However, in Huh-7 pre-
S2D cell line, the colony formation ability was more dramatically
decreased by co-treatment 5-fluorouracil with Bcl-2 inhibitor II
Y137. In addition, we also observed changes in Huh-7 pre-S2D cell
morphology after 5-fluorouracil with or without Bcl-2 inhibitor
treatment. As shown in Figure 7C, the 72-hours 5-fluorouracil
treatment, there were only minor morphologic changes after 72-
hours 5-fluorouracil treatment in Huh-7 pre-S2D cells. In contrast,
when a combination of 5-fluorouracil with Bcl-2 inhibitor Y II
YC137, progressive morphological changes from flat to round in
Huh-7 pre-S2D cells. Moreover, we examined the effect of 5-
fluorouracil or a combination of 5-fluorouracil with Bcl-2 inhibitor
II Y137 on modulating the activity of caspase-3 in Huh7 pre-S2D
cells by using flow cytometric analysis. As shown in Figure 7D,
exposure to 5-fluorouracil with or without Bcl-2 inhibitor II Y137
led to stimulation of caspase-3 activity (Fig. 7D). For example, 5-
fluorouracilcaused3-fold increase incaspase-3activity at 0.25 mM.
However, when co-incubation of 5-fluorouracil with Bcl-2 inhibitor
Figure 4. The pre-S2D large surface protein induced expression of Bcl-2 family proteins. (A) Total cell lysate was isolated from Huh-7 -V,
Huh-7 pre-S2D, and Huh-7 pre-S cells and then subjected to Western blotting analysis with Bcl-xL, Mcl-1, Bax, and Bad specific antibodies. (B) For Huh-
7 -V, Huh-7 pre-S2D, and Huh-7 pre-S cells, the relative levels of Bcl-xL, Mcl-1, Bax, and Bad protein were quantified. The data represent the mean of
Bcl-xL, Mcl-1, Bax, and Bad expression level from three independent experiments. Columns, mean; bars, SD (n=3). Significant differences (*, P,0.05)
between the control and experimental group are marked with an asterisks.
doi:10.1371/journal.pone.0028977.g004
Figure 5. Expression of pre-S2D large surface protein increased
ER stress and NF-kB, ERK, and Akt phosphorylation in Huh-7
cells. (A) (B) Cells were maintained in FBS–supplemented DMEM and
cell lysates were obtained by RIPA lysis buffer. The cell lysates were
determined by Western blotting using antibodies specific for GRP78,
NF-kB p65, p-Ser276 p65, p-Ser311 p65, ERK, p-ERK, Akt, p-AKTand
b-actin.
doi:10.1371/journal.pone.0028977.g005
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S2D cells compared with Huh-7 pre-S2D control cells (Fig. 7E). In
addition, to evaluate early apoptosis and late apoptosis (or necrosis),
the effects of 5-fluorouracil or a combination of 5-fluorouracil with
Bcl-2 inhibitor II Y137 on Huh-7 pre-S2D cells was determined by
Annexin V assay (Fig. 7F), which measures the transfer of
phosphatidylserine from the inner to the outer membrane of cells
and can detect both early and late apoptotic cells. As shown in
Figure 7G and H, the early apoptosis and late apoptosis (necrosis)
was significantly induced in Huh-7 pre-S2D cells after incubation of
0.25 mM 5-fluorouracil with or without Bcl-2 inhibitor for 24, 48,
and 72 h. For example, the late apoptosis (necrosis) indices of 5-
fluorouracil or a combination 5-fluorouracil with Bcl-2 inhibitor II
Y137 in 72 h treatment were 25 and 46%, respectively.
The combination of 5-fluorouracil and Bcl-2 inhibitor
induces the concomitant inhibition of Bcl-2, Bcl-xL and
Mcl-1 expression
To clarify the mechanism by which Bcl-2 inhibitor enhanced
the antitumor activities of the 5-fluorouracil, we examined the Bcl-
2 family expression status in treated Huh-7 pre-S2D cells (Fig. 7I).
The result indicated that the combination of 5-fluorouracil with
Bcl-2 inhibitor reduced expression level of Bcl-2, Bcl-xL and Mcl-
1. In addition, we also evaluated the effects of 5-fluorouracil with
or without Bcl-2 inhibitor on phosphorylation status of NF-kB,
AKT and ERK in Huh-7 pre-S2D cells. As shown in Fig. 7J, NF-
kB, Akt and ERK phosphorylation did not affect by 5-fluorouracil
or combination treatment.
Hepatitis B Virus Mutant Large Surface Protein Can
Induce Bcl-2 in Vivo
To confirm further that deletion forms of mutant HBV large
surface proteins can induce Bcl-2 in vivo, we created transgenic
mice that express the pre-S2 deletion form of HBV large surface
protein under the control of its native promoter. The expression of
HBV large surface protein was detected in the liver (Fig. 8A).
Elevated expression of Bcl-2 was observed in liver of pre-S2D
transgenic mice (Fig. 8B). Furthermore, to examine the event of
increased Bcl-2 expression by pre-S2D in hepatocytes, both control
and pre-S2D transgenic mice liver tissues were analyzed by
Figure 6. Expression of pre-S2D contributes to 5-fluorouracil treatment in Huh-7 cells. (A) The morphologic changes after a 96-hour
0.1 mM, 0.25 mM and 0.5 mM 5-fluorouracil treatment of Huh-7 V, Huh-7 pre-S2D, and Huh-7 Pre-S cells. The cells were followed by photography
under phase-contrast magnification. (B) Cytotoxicity of 5-fluorouracil to Huh-7 V, Huh-7 pre-S2D and Huh-7 pre-S cells were analyzed by trypan blue
staining assay. Columns, mean of three independent experiments; bars, SD (n=3). Significant differences (*, P,0.05) between the control and
experimental group are marked with an asterisks (C) Cell viability after treatment with 5-FU. Huh-7 V, Huh-7 pre-S2D and Huh-7 pre-S cells (1610
3)
were seeded in 6-well plate, as described in Materials and Methods. Cells were then incubated for another 10 days, and the colony formation ability of
three cell lines were evaluated using a crystal violet assay determined by crystal violet in response to 5-fluorouracil. (D) A quantitative measure of
colony formation was determined by crystal violet and the number of colonies in the graphs was representative of three independent experiments
(lower panel). Columns, mean; bars, SD (n=3). Significant differences (**, P,0.01 and ***, P,0.001) between the control and experimental group are
marked with an asterisks. (E) Flow cytometric analysis the effect of 5-fluorouracil on increasing caspase-3 activity in Huh7 V, Huh-7 pre-S2D, and Huh-
7 pre-S cells, increased caspase-3 activity was observed in Huh7 V, Huh-7 pre-S2D, and Huh-7 pre-S cells, after 72-h exposure to 5-Fluorouracil. (F) The
relative caspase-3 activities, normalized to DMSO control, at the indicated 0.25 mM of 5-fluorouracil. Columns, mean of three independent
experiments; bars, SD (n=3). Significant differences (*, P,0.05) between the control and experimental group are marked with an asterisks.
doi:10.1371/journal.pone.0028977.g006
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was found in pre-S2D transgenic mice hepatocytes. These results
altogether demonstrate that Pre-S mutant surface proteins can
induce Bcl-2 expression in vitro and in vivo.
Discussion
In this study, we show that HBV pre-S2D large surface protein
enhances Bcl-2 gene expression and alters chemotherapeutic drug
resistance by a mechanism involving Bcl-2 proto-oncogene
expression in human hepatoma cancer cells. Furthermore,
expression of Bcl-2 was increased by pre-S2D proteins in human
immortalized hepatocyte cells and pre-S2D transgenic mice liver
tissue. In addition, Bcl-2 family, Bcl-xL and Mcl-1, were increased
in Huh-7 pre-S2D cells. In Huh-7 pre-S2D and Huh-7 pre-S cells,
ER stress, Akt and ERK phosphorylation were also observed.
Moreover, resistant cells caused by expression of HBV pre-S2D
large surface protein could be sensitized by Bcl-2 inhibitor. Bcl-2
inhibitor overcomes drug resistance to 5-fluorouracil in Huh-7
pre-S2D cells, which provides a new approach to the combina-
tional therapy of HBV pre-S2D large surface protein-related
HCC. Overall, our data provide evidence for relationship between
Bcl-2 and HBV pre-S2D, and suggest that Bcl-2 gene is an
important determinant of drug-induced apoptosis thereby modu-
lating resistance to chemotherapy in HBV pre-S2D- containing
cells.
Modulation of apoptosis may influence resistance to chemo-
therapy, thus affecting the outcome of cancer treatment. Several
mechanisms of chemotherapeutic drug resistance in tumors, such
as overexpression of the multidrug resistance gene, increased DNA
Figure 7. Expression of Bcl-2 contributes to 5-fluorouracil resistance in Huh-7 pre-S2D cells. (A) Huh-7 V, Huh-7 pre-S2D and Huh-7 pre-S
cells (1610
3) were seeded in 6-well plates. Cells were treated with 5-fluorouracil with or without Bcl-2 inhibitor, as described in Materials and
Methods, and then incubated for another 10 days, and the colony formation ability of three cell lines were evaluated using a crystal violet assay
determined by crystal violet in response to 5-fluorouracil. (B) A quantitative measure of colony formation was determined by crystal violet and the
number of colonies in the graphs was representative of three independent experiments (lower panel). Data represent the mean 6 SD (n=3).
Significant differences (**, P,0.01 and ***, P,0.001) between the control and experimental group are marked with an asterisks. (C) The morphologic
changes after a 72-hour 0.25 mM 5-fluorouracil with or without Bcl-2 inhibitor treatment of Huh-7 pre-S2D cells. (D) The effect of 5-fluorouracil or
combination with Bcl-2 inhibitor on caspase-3 activity in Huh-7 pre-S2D cell line. Enzymatic activity of caspase-3 was determined by caspase-3
antibody, as described under ‘‘materials and methods’’. (E) The relative caspase-3 activities, normalized to DMSO control, at the indicated 0.25 mM 5-
fluorouracil or with 5 mM Bcl-2 inhibitor. Columns, mean of three independent experiments; bars, SD (n=3). Significant differences (***, P,0.001)
between the control and experimental group are marked with an asterisks. (F) Both apoptosis and necrosis were involved in 5-Fluorouracil or
combination with Bcl-2 inhibitor-induced cell death. Huh-7 pre-S2D cells were treated with 5-fluorourail with or without Bcl-2 inhibitor and cells were
analyzed by annexin V assay. (G) (H) The ratio of apoptotic and necrotic cells, normalized to DMSO control, at the indicated 0.25 mM 5-fluorouracil or
with 5 mM Bcl-2 inhibitor. Columns, mean of three independent experiments; bars, SD (n=3). Significant differences (*, P,0.05; ***, P,0.001) between
the control and experimental group are marked with an asterisks. (I) Downregulation of Bcl-2 family expression by combination 5-fluorouracil with
Bcl-2 inhibitor. Cells were treated with 5-fluorourail with or without Bcl-2 inhibitor and cell lysates were obtained by RIPA lysis buffer. The cell lysates
were determined by Western blotting using antibodies specific for Bcl-2, Bcl-xL, Mcl-1, Bax, Bak and b-actin. (J) The effect of 5-fluorouracil or
combination with Bcl-2 inhibitor on Akt, ERK and NF-kB phosphorylation in Huh-7 pre-S2D cell line. The total lysates were analyzed by Western
blotting using ERK, p-ERK, Akt, p-Akt, p65, p-ser
276-p65, p-ser
311-p65 and b-actin antibodies.
doi:10.1371/journal.pone.0028977.g007
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understood. An alternation of various regulatory genes in tumor
cells may also affect cellular sensitivity to chemotherapeutic drug.
The changes in genes expression involve a diverse group of gene
products, including oncogenes, tumor suppressor genes, cell cycle
regulators, transcription factors, DNA repair factors, growth factor
receptors, and cell death regulators. The multiple mechanisms of
intrinsic drug resistance are not thoroughly understood and may
involve the expression of multiple genes during tumor progression.
In this study, Bcl-2 expression was enhanced by HBV pre-S2D
large surface protein and the consequence of Bcl-2 expression was
associated with resistance to 5-fluorouracil in hepatoma cells. In
addition, the result has shown that phosphorylation of NF-kB p65
was increased in Huh-7 pre-S2D and Huh-7 pre-S cell lines.
Transcriptional activity of NF-kB is controlled by phosphorylation
of p65 at multiple serine residues. Here we show that induction of
p65 phosphorylation at Ser276 and Ser311 sites is induced in
Huh-7 pre-S2D and Huh-7 pre-S cells. In our previous studies, we
demonstrated that activation of NF-kB was enhanced by ER stress
through PERK-eIF2a signal pathway, pp38 kinase and calcium
signaling [21]. Activation of NF-kB regulates more than 100 gene
expressions as far as presently known. These genes have been
reported to be involved in diverse physiological conditions of cells,
such as inflammation and immune response, cell proliferation, cell
differentiation, and apoptosis [40]. The induction of NF-kB
activation by HBV pre-S2D large surface protein may practically
provide anti-apoptotic effect on chemotherapeutic treatment.
Taken together, the mechanisms of HBV pre-S2D large protein
in HCC are not fully understood and need further investigation.
In addition, other previous reports have indicated that
constitutive NF-kB activation is found in approximately 15–20%
of all cancers [41,42], and NF-kB has been associated with several
aspects of tumorigenesis. NF-kB plays an important role in gene
expression in cancer development. It inhibited proapoptotic gene
expression, induces anti-apoptotic gene expression [43], stimulates
cytokine production [44], induces angiogenesis via VEGF, IL-8,
PDGF [45], activation of various cell cycle genes [46], and
enhances the expression of the multidrug resistance (MDR)
protein and mediates chemoresistance of tumor cells [47]. On
the other hand, previous studies have indicated that NF-kB p65
mRNA and protein overexpression were detected in 5-fluoroura-
cil-resistant cancer cell lines [48]. The resistant cell lines had
higher NF-kB DNA binding and transcriptional activity. Inhibi-
tion of NF-kB activity can enhance the cytotoxicity of some
chemotherapeutic drugs. In addition, induction ERK and Akt
phosphorylation was observed in both Huh-7 pre-S and pre-S2D-
expressing cells. Taken together, these results may be able to
explain that although protein level of Bcl-2 was not altered in
Huh-7 pre-S cells, pre-S-expressing cells exhibited minor drug
resistant to 5-fluorouracil treatment.
Our previous studies indicate that overexpression of pre-S2D
large surface proteins have been demonstrated in the induction of
endoplasmic reticulum (ER) stress [18], oxidative stress and DNA
damage [49], COX-2 expression [21], cyclin A expression [50],
degradation of p27Kip1 [51], vascular endothelial growth factor-A
[12], interaction with a-acid glucosidase [52], and lipid upregula-
tion [53]. These results suggested that expression of HBV large
surface proteins, especially pre-S2D mutant, might be important
for hepatocarcinogenesis.
Similar to HBV pre-S2D large surface protein, Epstein-Barr
virus latent membrane protein 1 has been shown to induce Bcl-2
expression [54]. The up-regulating expression of the cellular
oncogene bcl-2 by EBV virus latent membrane protein 1 protects
infected B cells from programmed cell death. Therefore, induction
of the cellular oncogene bcl-2 expression has been demonstrated in
two different types of virus. The induction of the cellular oncogene
bcl-2 by other virus-encoded proteins warrants further investiga-
tion. In addition, recently, accumulating evidence has indicated
Figure 8. Elevated Bcl-2 is associated with pre-S2D expression in vivo. (A) Bcl-2 expression was elevated in transgenic mice expressing pre-S2
deletion (D2) HBV large surface protein. The expression of Bcl-2 in liver tissues (control and pre-S2D) was determined by Western blotting with
antibodies for pre-S, Bcl-2, and b-actin for three individual transgenic mice samples. The expression levels of Bcl-2 were quantified by using image J
software. The data represent the mean of Bcl-2 protein expression level from three independent experiments. Columns, mean; bars, SD (n=3).
Significant differences (*, P,0.05) between the control and experimental group are marked with an asterisks. (C) A marked increase of Bcl-2
expression in pre-S2D-expressing hepatocytes was observed. The expression of Bcl-2 and HBV surface proteins in liver tissues of control and pre-S2D
transgenic mice was analyzed by Immunohistochemical staining (6400).
doi:10.1371/journal.pone.0028977.g008
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expression is correlated with gene expression and various human
cancers development. For example, miR15b and miR-16 were
demonstrated to play a role in the development of MDR in gastric
cancer cells by targeting the antiapoptotic gene BCL2 [55].
Alternation of miRNA level by pre-S and pre-S2D in hepatoma
cells may also provide important role in resistance to chemother-
apeutic drugs.
Chemotherapy for the treatment of cancer became a clinical
practice more than 50 years ago. Although the chemotherapy has
successfully treated many types of tumors, including HCC, HCC
are inherently chemotherapy-resistant tumors and are known to
overexpress the drug-resistant genes. Thus, there is a clear need for
developing effective, life-prolonging therapeutic strategies for the
large number of HCC patients with advanced disease. In this
study, we reported that induction of cellular oncogene bcl-2
expression by HBV pre-S2D large surface proteins increased drug
resistance to 5-fluorouracil treatment and drug resistance can be
significantly decreased by co-incubation with Bcl-2 inhibitor.
Because the occurrences of HBV pre-S2D large surface proteins in
HBV cancer patients are about 30% [18]. Therefore, beside to
estimate HBV DNA levels in chronic HBV cancer patients, the
HBsAg DNA sequence should be analyzed before undergoing
systemic chemotherapy. That information of HBV pre-S2D large
surface protein with HBV chronic infection is an adverse factor for
survival and may be associated with a higher incidence of severe
hepatitis during chemotherapy. Taken together, these results may
provide a novel chemotherapeutic strategy for HBV pre-S2D large
surface protein tumor cells.
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